Shareholders Equity: The sum of preferred and common equity items.
BioAtla, Inc. (BCAB) had Shareholders Equity of $-36.19M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.00M |
|
$-59.61M |
|
-- |
|
$2.00M |
|
$61.30M |
|
$-59.30M |
|
$-0.30M |
|
$-59.61M |
|
$-59.61M |
|
$-59.61M |
|
$-59.61M |
|
$-59.61M |
|
$-59.61M |
|
$-59.30M |
|
$-58.93M |
|
1.18M |
|
1.18M |
|
$-50.50 |
|
$-50.50 |
|
| Balance Sheet Financials | |
$8.01M |
|
$0.12M |
|
$5.82M |
|
$13.83M |
|
$21.92M |
|
-- |
|
$28.09M |
|
$50.02M |
|
$-36.19M |
|
$-36.19M |
|
|
Shareholders Equity |
$-36.19M |
1.27M |
|
| Cash Flow Statement Financials | |
$-48.20M |
|
-- |
|
$6.28M |
|
$49.05M |
|
$7.12M |
|
$-41.93M |
|
$5.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2965.25% |
|
-2965.25% |
|
-2946.60% |
|
-2980.35% |
|
-2980.35% |
|
$-48.20M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
-- |
|
-- |
|
164.71% |
|
164.71% |
|
-431.06% |
|
164.71% |
|
$-28.51 |
|
$-40.97 |
|
$-40.97 |
|